N-of-One

N-of-One

Molecular decision support company providing clinicians with the most concise, accurate and clinically meaningful interpretation of molecular test results. Learn more
  • Edit
DateInvestorsAmountRound
N/A

$749k

Debt

$1.7m

Early VC

N/A

Early VC
N/A

$3.0m

Early VC

$7.0m

Series B
*

N/A

Acquisition
Total Funding$11.7m

Recent News about N-of-One

Edit
More about N-of-Oneinfo icon
Edit

N-of-One, a subsidiary of QIAGEN Digital Insights, specializes in providing expert-curated genomic and clinical knowledge, along with bioinformatics software and services. The company operates in the precision medicine market, focusing on delivering actionable insights from basic research to patient care. N-of-One serves a diverse range of clients including healthcare providers, research institutions, and pharmaceutical companies. The business model revolves around offering subscription-based access to its bioinformatics tools and services, as well as customized solutions tailored to specific client needs. Revenue is generated through these subscriptions, service fees, and consulting engagements. The company leverages cutting-edge technology such as whole exome sequencing and next-generation sequencing (NGS) analysis workflows to help clients uncover the significance of their data, identify new targets or candidate biomarkers, and improve clinical interpretations. N-of-One's cloud-enabled graphical user interface (GUI) and comprehensive NGS analysis workflows make it accessible for various workflows, ensuring immediate exploration and insights. The company also offers on-demand web seminars and tutorials to educate clients on the latest advancements in bioinformatics and genomic research.

Keywords: genomic knowledge, clinical insights, bioinformatics, precision medicine, whole exome sequencing, NGS analysis, biomarkers, cloud-enabled GUI, subscription-based, healthcare providers.

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.